Abstract
About 10 % of people will experience at least one seizure during lifespan, and one third of them will develop epilepsy. Antiepileptic drugs (AEDs) have hugely ameliorated the lives of people with epilepsy; however, 30–40 % of those individuals have seizures that cannot be totally controlled by medication. Ideally, one would like to prevent epilepsy in those with known risk but such therapies do not exist. Currently, treatment is exclusively based on the suppression of seizures by AEDs after epilepsy has already developed. Thus, understanding the basic mechanisms of epileptogenesis and epileptogenicity represents a priority for epilepsy research. In this respect, studies in human beings have a very limited capacity to explain such basic mechanisms. Consequently, animal models are invaluable tools of investigation. In this context, the wild Neotropical rodents Proechimys have been investigated in different experimental epilepsy paradigms. Interestingly, findings pointed to natural endogenous antiepileptogenic mechanisms in these rodents. Accordingly, Proechimys have been proposed as an animal model of resistance to epilepsy. This chapter sheds light to the potential use of these Neotropical animals in neuroscience research.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Andrioli A, Fabene PF, Spreafico R, Cavalheiro EA, Bentivoglio M. Different patterns of neuronal activation and neurodegeneration in the thalamus and cortex of epilepsy-resistant Proechimys rats versus Wistar rats after pilocarpine-induced protracted seizures. Epilepsia. 2009;50:832–48.
Araujo BH, Torres LB, Cossa AC, Naffah-Mazzacoratti Mda G, Cavalheiro EA. Hippocampal expression and distribution of CB1 receptors in the Amazonian rodent Proechimys: an animal model of resistance to epilepsy. Brain Res. 2010;1335:35–40.
Arida RM, Scorza FA, Carvalho RA, Cavalheiro EA. Proechimys guayannensis: an animal model of resistance to epilepsy. Epilepsia. 2005;46 Suppl 5:1–9.
Bailão Ribeiro NA, Pieczarka JC, Pereira Soares MC, Nagamachi CY. Identification of a long-standing colony of Proechimys at the Instituto Evandro Chagas, Pará, Brazil, based on cytogenetic information. Rev Pan-Amaz Saude. 2011;2:59–66.
Carvalho RA. Caracterização de modelos de epilepsia do lobo temporal em Proechimys guyannensis. PhD Thesis, Universidade Federal de São Paulo, SP, Brazil; 1999.
Carvalho RA, Arida RA, Cavalheiro EA. Amygdala kindling in Proechimys guyannensis rat: an animal model of resistance to epilepsy. Epilepsia. 2003;44:165–70.
Cavalheiro EA, Leite JP, Bortolotto ZA, Turski WA, Ikonomidou C, Turski L. Long-term effects of pilocarpine in rats: structural damage of the brain triggers kindling and spontaneous recurrent seizures. Epilepsia. 1991;32:778–82.
Dlugos DJ. The early identification of candidates for epilepsy surgery. Arch Neurol. 2001;58:1543.
Dudek FE, Clark S, Williams PA, Grabenstatter HL. Kainate-induced status epilepticus: A chronic model of acquired epilepsy. In: Pitkanen A, Schwartzkroin PA, Moshe SL, editors. Models of seizures and epilepsy. Boston: Elsevier Academic; 2006. p. 415–32.
Engel Jr J. Biomarkers in epilepsy: foreword. Biomark Med. 2011;5:529–30.
Fabene PF, Correia L, Carvalho RA, Cavalheiro EA, Bentivoglio M. The spiny rat Proechimys guyannensis as model of resistance to epilepsy: chemical characterization of hippocampal cell populations and pilocarpine-induced changes. Neuroscience. 2001a;104:979–1002.
Fabene PF, Bertini G, Correia L, Cavalheiro EA, Bentivoglio M. The thalamus of the Amazon spiny rat Proechimys guyannensis, an animal model of resistance to epilepsy, and pilocarpine-induced longterm changes of protein expression. Thal Relat Syst. 2001b;1:117–33.
Fabene PF, Andrioli A, Priel MR, Cavalheiro EA, Bentivoglio M. Fos induction and persistence, neurodegeneration, and interneuron activation in the hippocampus of epilepsy-resistant versus epilepsyprone rats after pilocarpine-induced seizures. Hippocampus. 2004;14:895–907.
Goffin K, Van Paesschen W, Van LaereIn K. In vivo activation of endocannabinoid system in temporal lobe epilepsy with hippocampal sclerosis. Brain. 2011;134:1033–40.
Klitgaard H, Pitkänen A. Antiepileptogenesis, neuroprotection, and disease modification in the treatment of epilepsy: focus on levetiracetam. Epileptic Disord. 2003;5:9–16.
Löscher W. Animal models of epilepsy for the development of antiepileptogenic and disease-modifying drugs. A comparison of the pharmacology of kindling and post-status epilepticus models of temporal lobe epilepsy. Epilepsy Res. 2002;50:105–23.
Löscher W. Critical review of current animal models of seizures and epilepsy used in the discovery and development of new antiepileptic drugs. Seizure. 2011;20:359–68.
Löscher W, Brandt C. Prevention or modification of epileptogenesis after brain insults: experimental approaches and translational research. Pharmacol Rev. 2010;62:668–700.
Machado T, Da Silva MNF, Leal-Mesquita ER, Carmignotto AP, Yonenaga-Yassuda Y. Nine karyomorphs for spiny rats of the genus Proechimys (Echimyidae, Rodentia) from North and Central Brazil. Genet Mol Biol. 2005;28:682–92.
Mani R, Pillard J, Dichter MA. Human clinical trials in antiepileptogenesis. Neurosci Lett. 2011;497(3):251–6.
Nowak RM. Walker’s mammals of the world, vol II. 6th ed. Baltimore: The Johns Hopkins University; 1999. p. 1688–9.
Patton JL, Da Silva MNF, Malcolm JR. Mammals of the Rio Juruá and the evolutionary and ecological diversification of Amazonia. Bull Am Mus Nat Hist. 2000;244:1–306.
Pitkänen A. Therapeutic approaches to epileptogenesis-hope on the horizon. Epilepsia. 2010;51 Suppl 3:2–17.
Scorza CA, Araujo BH, Arida RM, Scorza FA, Torres LB, Amorim HA, et al. Distinctive hippocampal CA2 subfield of the Amazon rodent Proechimys. Neuroscience. 2010;169:965–73.
Scorza CA, Araujo BH, Leite LA, Torres LB, Otalora LF, Oliveira MS, et al. Morphological and electrophysiological properties of pyramidal-like neurons in the stratum oriens of Cornu ammonis 1 and Cornu ammonis 2 area of Proechimys. Neuroscience. 2011;177:252–68.
Turski WA, Cavalheiro EA, Schwarz M, Czuczwar SJ, Kleinrok Z, Turski L. Limbic seizures produced by pilocarpine in rats: behavioural, electroencephalographic and neuropathological study. Behav Brain Res. 1983;9:315–35.
Weir BJ. Another hystricomorph rodent: keeping casiragua (Preochimys guairae) in captivity. Lab Animal. 1973;7:125–34.
Acknowledgments
FAPESP/CNPq/MCT-Instituto Nacional de Neurociência Translacional, CAPES and CInAPCe (Brazil).
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Scorza, C.A., Cavalheiro, E.A. (2013). Resistance to Epileptogenesis in the Neotropical Rodent Proechimys . In: Rocha, L., Cavalheiro, E. (eds) Pharmacoresistance in Epilepsy. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-6464-8_13
Download citation
DOI: https://doi.org/10.1007/978-1-4614-6464-8_13
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-6463-1
Online ISBN: 978-1-4614-6464-8
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)